Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis

Clinical trial NCT06716281 · RECRUITING

Trial details

NCT number: NCT06716281
Sponsor: Shanghai IxCell Biotechnology Co., LTD
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Knee Osteoarthritis

Start date: 2024-01-05
Primary completion: 2025-12-31
Enrollment: 398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.